These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 8146568)
41. Hormone replacement therapy: controversies, pros and cons. Warren MP; Halpert S Best Pract Res Clin Endocrinol Metab; 2004 Sep; 18(3):317-32. PubMed ID: 15261840 [TBL] [Abstract][Full Text] [Related]
42. Report from the Argentinian Association for Health Research and Development (ACINDES). Socioeconomic analysis of hormone replacement therapy: impact of consumer satisfaction on the outcomes of therapy. Int J Technol Assess Health Care; 1994; 10(4):710-1. PubMed ID: 7843891 [No Abstract] [Full Text] [Related]
43. [Considerations on the cost-benefit analysis and health-related effectiveness of estrogen therapy during menopause]. Schneider HP Med Welt; 1980 May; 31(22):828-33. PubMed ID: 6771485 [No Abstract] [Full Text] [Related]
44. [The effect of hormonal drugs used during menopause on the cardiovascular system]. Szymasiuk J; Sternadel Z; Bińkowska M Pol Tyg Lek; 1989 Dec 2-24; 44(49-52):970-2. PubMed ID: 2490303 [No Abstract] [Full Text] [Related]
50. When should postmenopausal women start taking oestrogen replacement therapy? Prince RL; Geelhoed EA Med J Aust; 1995 Feb; 162(4):173-4. PubMed ID: 7877535 [No Abstract] [Full Text] [Related]
52. [Evaluation of the action of a new non-steroidal estrogen (Zeranolo-Ralone)]. Menchini Fabris GF; Bianchi B Minerva Ginecol; 1977 Mar; 29(3):225-32. PubMed ID: 865724 [No Abstract] [Full Text] [Related]
55. [Present state of hormonal therapy of menopause pathologies (the 10th Conference of CMAS CLS JEP and SOM CGPS CLS JEP, October 16 to 18, 2009)]. Donát J Cas Lek Cesk; 2009; 148(12):659-61. PubMed ID: 20662397 [No Abstract] [Full Text] [Related]
57. One on one. Can I take hormone therapy for menopause if I have endometriosis? Mayo Clin Womens Healthsource; 2001 Dec; 5(12):8. PubMed ID: 14639203 [No Abstract] [Full Text] [Related]
58. [Socioeconomic stakes of menopause: evaluation of the cost-effectiveness studies]. Plu-Bureau G; Bureau D; Thalabard JC Rev Prat; 1993 Dec; 43(20):2665-9. PubMed ID: 8146568 [TBL] [Abstract][Full Text] [Related]
59. [The cost-effectiveness of hormonal replacement therapy]. Ylikorkala O Duodecim; 1996; 112(12):1039-40. PubMed ID: 10593003 [No Abstract] [Full Text] [Related]
60. Prognostic features of menopausal and postmenopausal applicants for life insurance. Schiefeling M J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]